Skip to main content

Displaying 1761 - 1780 of 2081

Oct17

Section 5 of the FTC Act as a Competition Statute

The Event The Federal Trade Commission will hold a public workshop on October 17, 2008, in Washington, D.C., to explore the scope of the prohibition of “unfair methods of competition” in Section 5 of...
May29

Clinical Integration in Health Care: A Check-Up

-
The Federal Trade Commission plans to hold a one-day public workshop to examine developments in the health care sector relating to “clinical integration” among health care providers. Clinical...
Apr24

Innovations in Health Care Delivery

The Federal Trade Commission will host a one-day public workshop on April 24, 2008, to examine recent trends in health care delivery. In a series of panel discussions, workshop participants will...
Feb12

Unilateral Effects Analysis and Litigation Workshop

-
The Federal Trade Commission is planning to host a public workshop on February 12, 2008 to examine the application of unilateral effects theory to mergers of firms that sell competing, but...
Feb13

Broadband Connectivity Competition Policy

-
The FTC hosted a public workshop on that brought together experts from business, government, and the technology sector, consumer advocates, and academics to explore competition and consumer protection...

Watson Pharmaceuticals, Inc. and Andrx Corporation., In the Matter of

A consent order settled charges that Watson Pharmaceuticals, Inc.’s proposed $1.9 billion acquisition of Andrx Corporation, would have likely led to competitive problems in the markets for 13 generic drug products. Watson was required to end its marketing agreements with Interpham Holdings, divest Andrx’s right to develop, make, and market generic extended release tablets that correct the effects of type 2 diabetes, and divest Andrx’s rights and assets related to the developing and marketing of 11 generic oral contraceptives.

There is a related federal proceeding and two related administrative proceedings:

Type of Action
Administrative
Last Updated
FTC Matter/File Number
0610139
Docket Number
C-4172